Export

You can select particular sections to be included in the output file.

Model List of Essential Medicines

clear Found 25 recommendations for 18 medicines and 8 therapeutic equivalents
Removed recommendations and rejected applications are shown. Hide them.
8.2.2. Targeted therapies
  1. Abemaciclib General information
    Section
    Targeted therapies
    Indications
  2. Afatinib General information
    Section
    Targeted therapies
  3. All-trans retinoic acid General information
    Section
    Targeted therapies
    • Oral > Solid: 10 mg capsule
  4. Binimetinib General information
    Section
    Targeted therapies
    Indications
  5. Bortezomib General information
    Section
    Targeted therapies
    • Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection
  6. Cobimetinib General information
    Section
    Targeted therapies
    Indications
  7. Crizotinib General information
    Section
    Targeted therapies
    • Oral > Solid: 200 mg; 250 mg
    • Oral > Solid > capsule: 200 mg; 250 mg
  8. Dabrafenib General information
    Section
    Targeted therapies
    • Oral > Solid: 50 mg; 75 mg
  9. Dasatinib General information
    Section
    Targeted therapies
    • Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet
  10. Encorafenib General information
    Section
    Targeted therapies
    Indications
  11. Erlotinib General information
    Section
    Targeted therapies
    • Oral > Solid: 100 mg; 150 mg
  12. Everolimus General information
    Section
    Targeted therapies
    • Oral > Solid: 2.5 mg; 5 mg; 7.5 mg; 10 mg; 2 mg tablet (dispersible); 3 mg tablet (dispersible); 5 mg tablet (dispersible)
  13. Gefitinib General information
    Section
    Targeted therapies
  14. Ibrutinib General information
    Section
    Targeted therapies
    • Oral > Solid: 140 mg
  15. Nilotinib General information
    Section
    Targeted therapies
    • Oral > Solid: 150 mg capsule; 200 mg capsule
  16. Osimertinib General information
    Section
    Targeted therapies
    • Oral > Solid: 40 mg (as mesylate); 80 mg (as mesylate)
  17. Palbociclib General information
    Section
    Targeted therapies
    • Oral > Solid: 75 mg; 100 mg; 125 mg
  18. Pertuzumab General information
    Section
    Targeted therapies
    • Parenteral > General injections > IV: 240 mg per 14 mL in vial concentrated solution
  19. Ribociclib General information
    Section
    Targeted therapies
    Indications
  20. Rituximab General information
    Section
    Targeted therapies
    • Parenteral > General injections > IV: 100 mg per 10 mL in 10 mL vial; 500 mg per 50 mL in 50 mL vial
  21. Trametinib General information
    Section
    Targeted therapies
    • Oral > Solid: 0.5 mg; 2 mg
  22. Trastuzumab General information
    Section
    Targeted therapies
    • Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection
  23. Trastuzumab emtansine General information
    Section
    Targeted therapies
    • Parenteral > General injections > IV: 100 mg in vial powder for injection; 160 mg in vial powder for injection
  24. Vemurafenib General information
    Section
    Targeted therapies
    Indications
  25. Zanubrutinib General information
    Section
    Targeted therapies
    • Oral > Solid: 80 mg